Schaumburg, Ill. -- The American Veterinary Medical Association?s (AVMA) Executive Board revised its policy on ?Use of Biotechnology in Development of Drugs and Vaccines? in April.
Schaumburg, Ill.
-- The American Veterinary Medical Association’s (AVMA) Executive Board revised its policy on “Use of Biotechnology in Development of Drugs and Vaccines” in April.
The revisions officially recognize the importance of biotechnology in drug and vaccine development, revealing how biotechnology use can help enhance surveillance and evaluate new developments with a science-based approach.
The amended policy can be found here.
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans
Read More